Texas standard prior authorization form Form

NOFR002 | 0522 1 of 3 Texas Standard Prior Authorization Request Form for Prescription Drug Benefits Please read all instructions below before completing this form.
Please send this request to the issuer from whom you are seeking authorization. Do not send this form to the Texas Department of Insurance, the Texas Health and Human Services Commission, or the patient’s or subscriber’s employer. Consistent with TDI rule 28 TAC Section 19.1820, health benefit plan issuers must accept the Texas Standard Prior Authorization Request Form for Prescription Drug Benefits if the plan requires prior authorization of a prescription drug or device. In addition to commercial issuers, the following public issuers must accept the form: Medicaid, the Medicaid managed care program, the Children’s Health Insurance Program (CHIP), and plans covering employees of the state of Texas, most school districts, and The University of Texas and Texas A&M Systems. Intended Use: Use this form to request authorization by fax or mail when an issuer requires prior authorization of a prescription drug, a prescription device, formulary exceptions, quantity limit overrides, or step-therapy requirement exceptions. An issuer may also provide an electronic version of this form on its website that you can complete and submit electronically, through the issuer’s portal, to request prior authorization of a prescription drug benefit. Do not use this form to: 1) request an appeal; 2) confirm eligibility; 3) verify coverage; 4) request a guarantee of payment; and 5) ask whether a prescription drug or device requires prior authorization; or 6) request prior authorization of a health care service. Additional Information and Instructions: Section I – Submission: Enter the name and contact information for the issuer or the issuer’s agent that manages or administers the issuer’s prescription drug benefits, as applicable. An issuer or agent may have already prepopulated its contact information on the copy of this form posted on its website. Section VI – Prescription Compound Drug Information: List the quantities of ingredients in units of measure (mg, ml, etc.). Section VIII – Patient Clinical Information: Enter current ICD version. Section IX – Justification: In the space provided or on a separate page: • Provide pertinent clinical information to justify requests for initial or ongoing therapy, or increases in current dosage, strength, or frequency. • Explain any comorbid conditions and contraindications for formulary drugs. • Provide details regarding titration regimen or oncology staging, if applicable. • Provide pertinent information about any step-therapy exception, if applicable. Read Texas Insurance Code Section 1369.0546(c) online.
Attach supporting clinical documentation (medical records, progress notes, lab reports, etc.), if needed. Note: Some issuers may require more information or additional forms to process your request. If you think more information or an additional form may be needed, please check the issuer’s website before faxing or mailing your request.

2 of 3 Texas Standard Prior Authorization Request Form for Prescription Drug Benefits Section I – Submission Submitted to: Phone: Fax: Date: Section II – Review Expedited/Urgent Review Requested: By checking this box and signing and dating below, I certify that applying the standard review time frame may seriously jeopardize the life or health of the patient or the patient’s ability to regain maximum function. Signature of Prescriber or Prescriber’s Designee: Date:

Section III – Patient Information Name: Phone: DOB:

Male
Female

Other
Unknown Address: City: State: ZIP Code: Issuer Name (if different from Section I): Member or Medicaid ID #: Group #: Section IV – Prescriber Information
Name: NPI #: Specialty: Address: City: State: ZIP Code: Phone: Fax: Office Contact Name: Contact Phone: Section V – Prescription Drug Information (If this is a compound drug, identify all ingredients in Section VI, below.) Requested Drug Name: Strength: Route of Administration: Quantity: Days’ Supply: Expected Therapy Duration: To the best of your knowledge this medication is:

New therapy
Continuation of therapy (approximate date therapy initiated:

For continuation of therapy, complete the following to the best of your knowledge: Patient is adhering to the drug therapy regimen. The drug therapy regimen is effective. Note: For a request for prior authorization of continuation of therapy (other than a request for a step-therapy exception as provided in 28 TAC Section 19.1820(a)(13)(B)), it is not necessary to complete Sections VIII or IX unless there has been a material change in the information previously provided. Section IX must be completed for a request for a step-therapy exception. For Provider Administered Drugs Only: HCPCS Code: NDC #: Dose Per Administration: Capital Rx 833-502-3339 833-434-0563 SIGN

3 of 3 Section VI – Prescription Compound Drug Information Compound Drug Name: Ingredient NDC # Quantity Ingredient NDC # Quantity Section VII – Prescription Device Information Requested Device Name: Expected Duration of Use: HCPCS Code (If applicable): Section VIII – Patient Clinical Information Patient’s diagnosis related to this request: ICD Version: ICD Code: (Provide the following information to the best of your knowledge) Drugs patient has taken for this diagnosis: Drug Name Strength Frequency Dates Started and Stopped or Approximate Duration Describe Response, Reason for Failure, or Allergy Drug Allergies: Height (if applicable): Weight (if applicable): Relevant laboratory values and dates (attach or list below): Date Test Value Section IX – Justification (See the “Additional Information and Instructions” section)